Greenleaf Trust Athenex, Inc. Transaction History

Greenleaf Trust

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.36 - $2.94 $1,551 - $3,354	-1,141 Reduced 0.87%	130,000 $177,000
Q3 2021 Nov 12, 2021	BUY	$2.97 - $4.84 $3,388 - $5,522	1,141 Added 0.88%	131,141 $395,000
Q1 2021 Apr 30, 2021	SELL	$4.08 - $14.75 $76,296 - $275,825	-18,700 Reduced 12.58%	130,000 $559,000
Q2 2020 Aug 12, 2020	SELL	$7.11 - $13.76 $71,100 - $137,600	-10,000 Reduced 6.3%	148,700 $2.05 Million
Q1 2020 Apr 29, 2020	SELL	$5.71 - $15.85 $165,019 - $458,065	-28,900 Reduced 15.41%	158,700 $1.23 Million
Q2 2019 Jul 24, 2019	SELL	$9.44 - $19.8 $273,760 - $574,200	-29,000 Reduced 13.39%	187,600 $3.71 Million
Q2 2018 Aug 07, 2018	SELL	$15.88 - $19.5 $1.72 Million - $2.12 Million	-108,528 Reduced 33.38%	216,600 $4.04 Million
Q1 2018 Apr 30, 2018	SELL	$13.53 - $17.47 $3.13 Million - $4.05 Million	-231,542 Reduced 41.59%	325,128 $5.53 Million
Q4 2017 Feb 08, 2018	BUY	$14.41 - $19.15 $1.28 Million - $1.71 Million	89,089 Added 19.05%	556,670 $8.85 Million
Q3 2017 Nov 13, 2017	BUY	$13.5 - $19.51 $6.31 Million - $9.12 Million	467,581	467,581 $8.19 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

Stay updated on Greenleaf Trust with notifications on news.